Christine A. Nash, SVP & Chief Commercial Officer at HYPERION THERAPEUTICS INC (HPTX), sold 9,900 shares at $29.32 ($293K) on 2015-03-09, disclosed to the SEC on 2015-03-10.
Scheduled sale ($293k) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.32 | 5,650 | $166K | 56.5% |
| 2 | $30.00 | 2,800 | $84K | 28.6% |
| 3 | $30.10 | 1,450 | $44K | 14.9% |
| Total | $29.63 avg | 9,900 | $293K | 100% |
| Filing → |
| HPTX | SELL | 2015-01-22 | $124K | — | Filing → |
| HPTX | SELL | 2014-03-10 | $148K | — | Filing → |
| HPTX | SELL | 2014-01-14 | $241K | — | Filing → |